FDA Recalls Nature Mint Toothpaste for Manufacturing Quality Deviations
The FDA has recalled Nature Mint Anticavity Fluoride Toothpaste due to manufacturing quality control violations. The affected product was distributed to Delaware and North Carolina.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall initiated voluntarily without reported illnesses or injuries. The recall is for CGMP deviations (manufacturing process violations), which represents a theoretical risk without identified specific adverse events. Voluntary precautionary recalls of this type are typically scored as Moderate.
Plain-English summary
Nature Mint Anticavity Fluoride Toothpaste, containing sodium monofluorophosphate 0.76% and packaged in 4.6 oz (130 gram) tubes, has been recalled. The product was manufactured in India and distributed by Bob Barker Co. Inc. to Delaware and North Carolina.
The recall was initiated on April 24, 2025, due to deviations in current good manufacturing practice (CGMP) standards. The manufacturer, Kenil Healthcare Private Limited, voluntarily initiated this recall.
Affected lot numbers are B0027 and B0031 (expiration date 06/30/2026) and B0032 (expiration date 07/31/2026). Consumers should check their products against these lot numbers.
If you have purchased this product with one of the affected lot numbers, discontinue use and dispose of it safely. For additional information, consult the FDA website or contact the distributor.
The recalled product
- Product
- Nature Mint, Anticavity Fluoride Toothpaste, Sodium monofluorophosphate 0.76%, NET WT 4.6 OZ (130 grams) Tube, Made in India, Dist. by Bob Barker Co. Inc., Fuquay-Varina, NC 27526, NDC 53247-131-06
- Manufacturer
- KENIL HEALTHCARE PRIVATE LIMITED
- Category
- Drug — Oral Care / Toothpaste
- Hazard
- cgmp-deviation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (5)
- Lot B0027
- B0031
- Exp Date: 06/30/2026
- Lot B0032
- Exp Date: 07/31/2026
Distribution
Distributed in 2 states:
- DE
- NC
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27